This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of ENGERIX-B 20 MCG/ML SYRNML, a hepatitis B vaccine. The contract has a ceiling value of $12,016.55 and will be completed by December 10, 2024. It is a delivery order contract with a firm fixed price pricing type. This award is not associated with a set-aside program. The contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.
Generated 3/16/25, 12:49 AM